🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Don’t miss our live TAVI transmission from AUBMC to SHS Mumbai this Saturday #AUBMC #SHSMumbai #TAVI Ziyad Ghazzal Samir Alam MD FACC FRCP American University of Beirut Medical Center Wail AlkashkariFSCAI,FPICSوائل القشقرى🇸🇦🇨🇦🇺🇲 MIЯVΛƬ #IC Ronnie Ramadan, MD

Happy to share our work on mechanisms of VF in explanted human hearts. Thank you to Mani A Daneshmand for helping us with this endeavor. If you could also stop doing transplants at 3 AM, then I could get some sleep :-) tinyurl.com/2rbcbtfj Faisal Merchant Mikhael El-Chami

#CardioLibya23-Benghazi Kicking off a dense HF session with friends and colleagues from around the world.

Innovation in #HeartTxp and #cardiac care under extreme duress presented by Borys Todurov of the Heart Institute of the Ministry of Health of Ukraine. #ISHLT2024

Very thought-provoking session about Novel MSC technologies at #ISHLT24 by some of the greatest in MCS science

We are pleased to inform that our DOT-HM3 Trial results in partnership between IKEM and The Brigham Harvard just got online! Our results suggest a safety signal of Apixaban use with the HM3 up to a 6-months time point in stable LVAD patients. ahajournals.org/doi/abs/10.116…

Manreet Kanwar presents powerful data on improving both quality and duration of life in LVAD patients. Optimize hemodynamics. GDMT for remission/recovery. Monitor drive line like it’s a “third limb.” Silver, chlorhexadine, and stringent diabetes control. #ishlt2024 The ISHLT

Kiran Khush stealing the show with the first report from CareDx® SHORE registry! Dual + GEP/cfDNA with the highest incidence of rejection and more predictive of future events than biopsies! The ISHLT JHLT #ishlt2024 Shout out to all of our co-investigators!

Fantastic talks by Brian Wayda on the many reasons for donor heart refusal that don’t make any objective sense! Challenge the dogma to expand donor heart utilization. #ISHLT2024 ⁦Stanford Heart Failure, Cardiac Transplant and MCS⁩ ⁦The ISHLT⁩ ⁦Eldrin Lewis⁩

Wrapped up an excellent meeting at #ISHLT24 in Prague, CZ. Emory representatives with these bright and intelligent young doctors. The future of HF therapy is strong. @Noah Newman Rebecca Steinberg, MD, MSc Adithya K. Yadalam, MD Martin Osario Nader Krishan Patel.

Wrapped up an excellent meeting at #ISHLT24 in Prague, CZ. Emory representatives with these bright and intelligent young doctors. The future of HF therapy is strong. @Noah Newman Rebecca Steinberg, MD, MSc Adithya K. Yadalam, MD Martin Osario Nader Krishan Patel. Divya Gupta, MD Mani A Daneshmand

🚨Stunning!🚨 REVERSAL in the decline of heart failure ☠️ in the US 1999-2021 1999-2005 ⬇️ ☠️ 2005-2012 ⬇️ ☠️ 2012-2019 ⬆️ ☠️ 2019-2021 ⬆️⬆️☠️ Age-adjusted HF related ☠️ rates higher in 2021 vs 1999! WT😱🆘 jamanetwork.com/journals/jamac… JAMA Cardiology Marat Fudim, MD MHS

Neal Kumar Bhatia presenting data on using upstream sinus electrograms to predict impending onset of VT/VF. Upstream sinus likely holds pathophysiologic insights to why arrhythmias occur and may open door to preventive strategies HRX Heart Rhythm Society Emory Cardiology Mikhael El-Chami

Wrapped up our BrioHealth Solutions Core Training with Mani A Daneshmand and Divya Gupta, MD! Will be 1 of only 8 programs kicking off this groundbreaking clinical trial of a new MagLev LVAD system!

Wonderful kick off session for a successful conference at CardioLibya 10 in Misrata, Libya Aiman Smer Mahmoud Traina Feras Bader Khaled Ellafi

Strong 1st HF session at #CardioLibya10 with leila abid @mohammedharrari Feras Bader Excellent discussions and great updated data

There was punching, grinding and a fruitful debate on role of revascularization in ICM at #CardioLibya10 Adel Dyub Bassem Albarouni Osama Elgusbi

The HF sessions wrapped up in a great session about special cardiomyopathies. #CardioLibya10 was a success...! Congratulations to Libya despite all hardships LCS delivers a great annual conference..!

Kidney transplant recipients receiving GLP-1 RA had a 49% lower incidence of death-censored graft loss and 31% lower mortality than those not receiving GLP-1 RA 🤯 Proud to be a co-author on this real-world retrospective cohort study of 18,106 kidney transplant recipients with

Emory Cardiology Research Day, our superstar resident Martin Osario-Nader showcasing great work on renal impairment and HM3 LVAD...